| Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 |
|---|---|---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||
Net earnings | ||||||||||
96,072 | 126,150 | 76,086 | 104,476 | 107,735 | 110,948 | 112,561 | 112,331 | 112,302 | 109,776 | 105,242 |
Adjustments to reconcile net earnings to net cash provided by operating activities: | ||||||||||
Depreciation and amortization | ||||||||||
78,171 | 64,463 | 60,036 | 42,764 | 37,226 | 19,175 | 12,321 | 12,467 | 8,700 | 8,130 | 7,766 |
Costs recognized on sale of acquired inventory | ||||||||||
3,739 | 2,455 | 3,037 | 5,431 | 6,961 | 7,480 | 4,501 | 7,573 | 1,835 | 0 | 0 |
Deferred income taxes | ||||||||||
-13,582 | -46,716 | -3,433 | -2,624 | 1,304 | -2,853 | -2,534 | -7,363 | 3,194 | -1,551 | -730 |
Stock-based compensation expense | ||||||||||
32,280 | 28,240 | 14,631 | 9,430 | 5,957 | 3,523 | 1,864 | 1,641 | 1,138 | 1,135 | 1,478 |
Gain on sale of CyVek | ||||||||||
- | - | - | - | 8,300 | 0 | 0 | - | - | - | - |
Fair value adjustment to contingent consideration payable | ||||||||||
-2,000 | 20,100 | 18,400 | 0 | 0 | - | - | - | - | - | - |
Gain on investment, net | ||||||||||
3,702 | 397 | - | 0 | - | - | - | - | - | - | - |
Fair value adjustment on available for sale investments | ||||||||||
16,067 | - | - | - | - | - | - | - | - | - | - |
Other operating activity | ||||||||||
2,325 | 776 | 2,215 | -279 | 157 | -592 | -763 | -230 | -225 | -222 | -458 |
Impairment losses on investments | ||||||||||
- | - | - | - | - | - | - | 3,254 | 0 | 0 | - |
Net (gain) loss from equity method investees | ||||||||||
- | - | - | - | - | - | 570 | -603 | -926 | -1,510 | -1,290 |
Change in operating assets and operating liabilities, net of acquisition: | ||||||||||
Trade accounts and other receivables, net | ||||||||||
15,000 | 2,700 | 19,686 | 22,981 | 11,747 | -1,145 | 2,334 | 2,096 | 3,624 | 4,034 | -49 |
Inventories | ||||||||||
13,647 | 13,327 | 732 | 6,626 | 4,714 | 2,895 | 2,216 | 1,577 | 1,021 | 2,368 | 2,123 |
Other current assets | ||||||||||
698 | -2,782 | 2,088 | 381 | 620 | 554 | 33 | 476 | -256 | 186 | 42 |
Trade accounts payable, accrued expenses, contract liabilities, and other | ||||||||||
6,101 | 5,026 | 5,695 | 8,924 | 2,154 | 1,368 | 243 | 1,581 | -591 | -74 | 1,394 |
Contingent consideration payable | ||||||||||
- | -26,600 | -11,800 | 0 | 0 | - | - | - | - | - | - |
Salaries, wages and related accruals | ||||||||||
5,013 | -89 | 661 | 5,725 | 1,679 | 1,034 | -92 | 686 | 1,268 | 414 | -2,803 |
Income taxes payable | ||||||||||
-9,520 | 10,204 | 699 | 298 | 1,881 | -1,939 | -837 | -2,057 | 3,433 | -1,518 | -551 |
Net cash provided by operating activities | ||||||||||
181,619 | 170,367 | 143,721 | 144,157 | 139,359 | 136,762 | 123,562 | 126,746 | 127,194 | 111,260 | 111,321 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||
Proceeds from sales of available-for-sale investments | ||||||||||
- | - | - | - | - | - | - | 64,291 | 134,019 | 27,045 | 41,352 |
Proceeds from sale and maturities of available-for-sale investments | ||||||||||
21,579 | 36,390 | 6,079 | 776 | 13,466 | 289,410 | 103,610 | 67,435 | 39,501 | 39,555 | 34,315 |
Purchases of available-for-sale investments | ||||||||||
43,475 | 8,571 | 3,069 | 0 | 0 | 106,746 | 112,712 | 147,011 | 151,366 | 176,621 | 49,173 |
Additions to property and equipment | ||||||||||
25,411 | 20,934 | 15,179 | 16,898 | 19,905 | 13,821 | 22,454 | 6,017 | 3,630 | 4,644 | 6,556 |
Acquisitions, net of cash acquired | ||||||||||
289,492 | 67,851 | 253,785 | 91,423 | 420,102 | 109,180 | 0 | 0 | 131,766 | 0 | 0 |
Investment in unconsolidated entity | ||||||||||
- | -21,574 | 40,000 | 0 | - | - | - | - | - | - | - |
Purchase of equity investment | ||||||||||
- | - | - | - | 0 | 10,000 | 0 | 0 | - | - | - |
Other investing activities | ||||||||||
- | -680 | - | 25 | -49 | -25 | -352 | 366 | 943 | 0 | 0 |
Distributions from unconsolidated entities | ||||||||||
- | - | - | - | - | - | - | - | 0 | 50 | 1,340 |
Net cash provided by (used in) investing activities | ||||||||||
-336,799 | -38,712 | -305,954 | -107,570 | -426,492 | 49,688 | -31,204 | -21,668 | -114,185 | -114,615 | 21,278 |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||
Cash dividends | ||||||||||
48,364 | 47,973 | 47,325 | 47,607 | 47,107 | 45,394 | 43,463 | 41,018 | 39,691 | 38,388 | 28,194 |
Proceeds from stock option exercises | ||||||||||
37,950 | 19,170 | 5,257 | 5,458 | 9,731 | 8,326 | 1,105 | 847 | 4,790 | 3,261 | 953 |
Purchase of common stock for stock bonus plans | ||||||||||
- | - | - | - | - | - | 573 | 907 | 294 | 607 | 1,681 |
Re-purchase of common stock | ||||||||||
15,405 | - | - | - | - | - | 1,821 | 23,598 | 1,940 | 14,973 | 90,629 |
Excess tax benefit from stock option exercises | ||||||||||
- | - | 514 | - | - | 262 | 75 | 51 | 847 | 196 | 107 |
Proceeds from long-term debt | ||||||||||
580,000 | 55,000 | 368,500 | 77,000 | 163,000 | 0 | 0 | - | - | - | - |
Repayments of long-term debt | ||||||||||
413,500 | 59,500 | 116,500 | 58,500 | 94,964 | 0 | 0 | - | - | - | - |
Payment of contingent consideration | ||||||||||
- | 61,900 | 20,316 | 0 | 0 | - | - | - | - | - | - |
Other financing activity | ||||||||||
-6,297 | -3,985 | -1,017 | -287 | - | - | - | - | - | - | - |
Net cash provided by (used in) financing activities | ||||||||||
134,384 | -99,188 | 189,113 | -23,370 | 31,275 | -36,806 | -44,677 | -64,625 | -36,288 | -50,511 | -119,444 |
Effect of exchange rate changes on cash and cash equivalents | ||||||||||
-308 | -2,089 | 495 | -3,512 | -8,178 | 5,138 | -570 | -1,391 | 6,753 | -12,935 | -19,207 |
Net increase (decrease) in cash and cash equivalents | ||||||||||
-21,104 | 30,378 | 27,375 | 9,705 | -264,036 | 154,782 | 47,111 | 39,062 | -16,526 | -66,801 | -6,052 |